Disease-modifying treatments and novel symptomatic therapies with innovative mechanisms of action will enter the arena during the forecast period and become routinely used in care.
A new treatment for melanoma could be on the horizon. The authors of a new study report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Only 34 out of 133 countries participating in the recent survey of countries in the six WHO regions have a comprehensive national plan to fight resistance to antibiotics and other antimicrobial medicines.
An analysis of Genocea Biosciences’ investigational genital herpes (GH) vaccine, GEN-003.
The widely held belief that depression is caused by low levels of serotonin and that certain antidepressants raise the levels of this neurotransmitter, is a myth, according to a psychiatrist in an editorial article in The BMJ this week.
The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.
The future growth of the non-vascular stent market by 2021 will be slower in the US than almost every other major market.
This method is delivering some promising results in early trials.
Here are the winners of the INTERPHEX Exhibitor Awards for 2015.
Access to high-quality medicine is a basic human right, but more than four billion people live in countries where many medications are substandard or fake.
One of the main sessions at this year’s Experimental Biology Conference in Boston was the Tang Prize Award lecture.
A single cell type in the skin of mice is a major contributor to scarring after wound healing or radiation damage, and facilitates the growth of melanoma. Blocking the cell’s activity in humans may be possible with currently approved drugs.
Research suggests strategy to prevent relapse after therapies targeting tumor blood vessels.
A wearable device that emits low-level electrical fields can slow the progression of glioblastoma, the deadliest form of brain cancer, and extend patients’ lifespans.
French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial.
Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer’s given an experimental cancer drug.
With this award, Stanford has received a total of around $297 million from CIRM.
HIV can establish itself in the brain as soon as four months after initial infection.
A team of researchers has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease.
Scientists call for a global strategy for the development of new tuberculosis vaccines.
Study finds vaccination rate far below what's needed to keep virus in check.
Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton.
The project will focus on finding cures for aging-related diseases like cataracts and atherosclerosis.
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.